U.S. markets open in 9 hours 10 minutes
  • S&P Futures

    4,136.25
    +8.50 (+0.21%)
     
  • Dow Futures

    33,757.00
    +48.00 (+0.14%)
     
  • Nasdaq Futures

    13,777.50
    +27.25 (+0.20%)
     
  • Russell 2000 Futures

    2,244.50
    +16.20 (+0.73%)
     
  • Crude Oil

    61.83
    +0.40 (+0.65%)
     
  • Gold

    1,785.40
    +3.40 (+0.19%)
     
  • Silver

    26.19
    +0.01 (+0.04%)
     
  • EUR/USD

    1.2028
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    1.5540
    -0.0100 (-0.64%)
     
  • Vix

    18.71
    +1.21 (+6.91%)
     
  • GBP/USD

    1.3861
    +0.0018 (+0.13%)
     
  • USD/JPY

    107.9300
    -0.0300 (-0.03%)
     
  • BTC-USD

    49,910.57
    -4,106.20 (-7.60%)
     
  • CMC Crypto 200

    1,132.55
    -110.50 (-8.89%)
     
  • FTSE 100

    6,938.24
    +42.95 (+0.62%)
     
  • Nikkei 225

    28,937.39
    -250.78 (-0.86%)
     

Ra Medical Systems to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present a company overview and hold virtual meetings with investors at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021.

The Ra Medical Systems presentation can be accessed by registering for the H.C. Wainwright Global Life Sciences Virtual Conference here. The webcast will be available on the H.C. Wainwright Conference Portal beginning March 9, 2021 at 7:00 a.m. Eastern time through March 10, 2021 at 9:00 p.m. Eastern time. The Company’s corporate presentation can be accessed from the Investor Relations section of the Company website here.

About Ra Medical Systems

Ra Medical Systems commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017 the DABRA excimer laser system received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions, or CTOs, in patients with symptomatic infrainguinal lower extremity vascular disease with an intended use for ablating a channel in occlusive peripheral vascular disease. The Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are both based on Ra Medical’s core excimer laser technology platform and deploy similar mechanisms of action. Ra Medical manufactures DABRA and Pharos excimer lasers and catheters in a 32,000-square-foot facility located in Carlsbad, Calif. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in controlled environments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005253/en/

Contacts

At the Company:
Andrew Jackson
Chief Financial Officer, Ra Medical Systems
760-496-9540
ajackson@ramed.com

Investors:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com